XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Stock award plan - (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Summary of stock option activity

    

    

    

Weighted-

    

  

Weighted-

average

Aggregate

average

remaining

intrinsic

Number of

exercise

contractual

value(in 

options

price

term

thousands)

 

Outstanding at December 31, 2020

 

9,663,677

$

38.72

 

  

 

  

Granted

 

2,403,484

62.21

 

  

 

  

Exercised

 

(574,230)

28.11

 

  

 

  

Forfeited/Cancelled

 

(610,850)

52.52

 

  

 

  

Outstanding at September 30, 2021

 

10,882,081

$

43.70

 

7.16

years

$

39,772

Vested or Expected to vest at September 30, 2021

 

4,802,564

$

50.12

 

8.47

years

$

6,311

Exercisable at September 30, 2021

 

5,585,904

$

37.32

 

5.88

years

$

33,232

Schedule of assumptions used to estimate fair values of grants made on the date of grant

    

Nine months ended

    

September 30, 2021

Risk-free interest rate

 

0.51%-1.05%

Expected volatility

 

77.53%-88.61%

Expected term

 

5.5 years

Summary of information on the Company's restricted stock

Restricted Stock Awards and Units

Weighted

Average

Grant

Number of

Date

    

Shares

    

Fair Value

Unvested at December 31, 2020

982,058

$

41.78

Granted

 

994,603

63.15

Vested

 

(326,519)

35.49

Forfeited

 

(113,877)

57.95

Unvested at September 30, 2021

 

1,536,265

$

55.76

Schedule of share-based compensation expense recorded in the statement of operations

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2021

    

2020

    

2021

    

2020

Research and development

$

13,048

$

9,220

$

40,216

$

25,961

Selling, general and administrative

 

12,823

 

7,559

 

37,061

 

22,948

Total

$

25,871

$

16,779

$

77,277

$

48,909